BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31427908)

  • 1. Prediction of Chemotherapy Response of Osteosarcoma Using Baseline
    Jeong SY; Kim W; Byun BH; Kong CB; Song WS; Lim I; Lim SM; Woo SK
    Contrast Media Mol Imaging; 2019; 2019():3515080. PubMed ID: 31427908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center
    Kim J; Jeong SY; Kim BC; Byun BH; Lim I; Kong CB; Song WS; Lim SM; Woo SK
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can pretreatment
    Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
    Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textural features of
    Cheng L; Zhang J; Wang Y; Xu X; Zhang Y; Zhang Y; Liu G; Cheng J
    Ann Nucl Med; 2017 Aug; 31(7):544-552. PubMed ID: 28646331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
    Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O
    Clin Radiol; 2021 Sep; 76(9):711.e1-711.e7. PubMed ID: 33934877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of
    Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
    Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.
    Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1553-62. PubMed ID: 24652233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas.
    Ben Bouallègue F; Tabaa YA; Kafrouni M; Cartron G; Vauchot F; Mariano-Goulart D
    Med Phys; 2017 Sep; 44(9):4608-4619. PubMed ID: 28513853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
    Groheux D; Majdoub M; Tixier F; Le Rest CC; Martineau A; Merlet P; Espié M; de Roquancourt A; Hindié E; Hatt M; Visvikis D
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1682-1691. PubMed ID: 26140849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
    Tixier F; Le Rest CC; Hatt M; Albarghach N; Pradier O; Metges JP; Corcos L; Visvikis D
    J Nucl Med; 2011 Mar; 52(3):369-78. PubMed ID: 21321270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an
    Tsujikawa T; Yamamoto M; Shono K; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Okazawa H; Yoshida Y
    Ann Nucl Med; 2017 Dec; 31(10):752-757. PubMed ID: 28905201
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tsujikawa T; Rahman T; Yamamoto M; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Yoshida Y; Okazawa H
    Ann Nucl Med; 2017 Nov; 31(9):678-685. PubMed ID: 28815452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral heterogeneity in
    Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
    Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
    He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
    Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
    Dutour A; Decouvelaere AV; Monteil J; Duclos ME; Roualdes O; Rousseau R; Marec-Bérard P
    J Nucl Med; 2009 Sep; 50(9):1533-40. PubMed ID: 19690032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.
    Hyun SH; Kim HS; Choi SH; Choi DW; Lee JK; Lee KH; Park JO; Lee KH; Kim BT; Choi JY
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1461-8. PubMed ID: 26872788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with
    Lemarignier C; Martineau A; Teixeira L; Vercellino L; Espié M; Merlet P; Groheux D
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1145-1154. PubMed ID: 28188325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning and Texture Analysis of [
    Hakkak Moghadam Torbati A; Pellegrino S; Fonti R; Morra R; De Placido S; Del Vecchio S
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.